US FDA. GUIDANCE. DEMONSTRATING BIOEQUIVALENCE FOR SOLUBLE POWDER ORAL DOSAGE FORM PRODUCTS AND TYPE A MEDICATED ARTICLES CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS CONSIDERED TO BE SOLUBLE IN AQUEOUS MEDIA. #171. MAY 2021.